These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31733527)

  • 21. Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
    Lopez-Espinosa MJ; Mondal D; Armstrong BG; Eskenazi B; Fletcher T
    Environ Health Perspect; 2016 Aug; 124(8):1269-75. PubMed ID: 26794451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
    Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
    Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.
    Timmermann CA; Budtz-Jørgensen E; Jensen TK; Osuna CE; Petersen MS; Steuerwald U; Nielsen F; Poulsen LK; Weihe P; Grandjean P
    J Immunotoxicol; 2017 Dec; 14(1):39-49. PubMed ID: 28091126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration and correlations of perfluoroalkyl substances in whole blood among subjects from three different geographical areas in Korea.
    Cho CR; Lam NH; Cho BM; Kannan K; Cho HS
    Sci Total Environ; 2015 Apr; 512-513():397-405. PubMed ID: 25638654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort.
    Beck IH; Timmermann CAG; Nielsen F; Schoeters G; Jøhnk C; Kyhl HB; Høst A; Jensen TK
    Environ Health; 2019 Nov; 18(1):97. PubMed ID: 31730470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between maternal serum concentration of perfluoroalkyl substances (PFASs) at delivery and acute infectious diseases in infancy.
    Wang Z; Shi R; Ding G; Yao Q; Pan C; Gao Y; Tian Y
    Chemosphere; 2022 Feb; 289():133235. PubMed ID: 34896425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies.
    Papadopoulou E; Haug LS; Sabaredzovic A; Eggesbø M; Longnecker MP
    Environ Res; 2015 Jul; 140():421-9. PubMed ID: 25957838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Per- and poly-fluoroalkyl substances (PFASs) in follicular fluid from women experiencing infertility in Australia.
    Kim YR; White N; Bräunig J; Vijayasarathy S; Mueller JF; Knox CL; Harden FA; Pacella R; Toms LL
    Environ Res; 2020 Nov; 190():109963. PubMed ID: 32745751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia.
    Banjabi AA; Li AJ; Kumosani TA; Yousef JM; Kannan K
    Environ Res; 2020 Aug; 187():109676. PubMed ID: 32485360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfluoroalkyl substance exposure and urine CC16 levels among asthmatics: A case-control study of children.
    Zhou Y; Bao WW; Qian ZM; Dee Geiger S; Parrish KL; Yang BY; Lee YL; Dong GH
    Environ Res; 2017 Nov; 159():158-163. PubMed ID: 28802206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.